Mylan launches olanzapine tablets

PITTSBURGH — Mylan on Wednesday announced that it has launched olanzapine orally disintegrating tablets in 5-mg, 10-mg, 15-mg and 20-mg strengths. The drug is the generic version of Zyprexa Zydis tablets from Eli Lilly and Co.



The drug is used for the treatment of schizophrenia or the acute treatment of manic or mixed episodes associated with bipolar I disorder and maintenance treatment of bipolar I disorder. Olanzapine ODT had U.S. sales of $120.8 million for the 12 months ending March 31, 2014, according to IMS Health.